ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
James Todd
Hiroki Sato
Jakob Vinten-Johansen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Todd, J.
Right arrow Articles by Vinten-Johansen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Todd, J.
Right arrow Articles by Vinten-Johansen, J.

Ann Thorac Surg 1996;62:1364-1372
© 1996 The Society of Thoracic Surgeons


Original Article: Cardiovascular

Intravascular Adenosine at Reperfusion Reduces Infarct Size and Neutrophil Adherence

James Todd, MD, Zhi-Qing Zhao, MDPhD, Mark W. Williams, BS, Hiroki Sato, MDPhD, David G. L. Van Wylen, PhD, Jakob Vinten-Johansen, PhD

Department of Cardiothoracic Surgery Research Laboratory, Bowman Gray School of Medicine, Winston-Salem, North Carolina

Accepted for publication May 29, 1996.

Background. Adenosine has been shown to reduce infarct size predominantly during reperfusion by adenosine A2–receptor-mediated processes. This cardioprotection may involve inhibition of events in the vascular compartment, such as adherence-independent and adherence-dependent actions of neutrophils. This study tested the hypothesis that adenosine exerts its cardioprotection during reperfusion by targeting effectors in the vascular compartment.

Methods. Polyadenylic acid (molecular weight, 230,000 daltons) was used as an intravascularly confined adenosine mimetic. In anesthetized New Zealand white rabbits, the left coronary artery was occluded for 30 minutes and reperfused for 120 minutes.

Results. Polyadenylic acid (1 mg/kg bolus, 0.5 mg • kg-1 • h-1) given 5 minutes before reperfusion significantly (p < 0.05) reduced infarct size compared with vehicle (23% ± 2% versus 37% ± 2% area at risk). The A1-antagonist KW-3902 had no effect on this polyadenylic acid-induced protection (17% ± 3%), whereas the A1-A2 antagonist sulfophenytheophylline blocked this infarct size reduction (41% ± 2%). In vitro adherence of platelet-activating factor-activated neutrophils to thoracic aortic endothelium was significantly diminished by polyadenylic acid (185 ± 12 neutrophils/mm2 versus 36 ± 4 neutrophils/mm2 endothelial surface). Sulfophenytheophylline inhibited this effect (280 ± 6 neutrophils/mm2), whereas KW-3902 did not (31 ± 7 neutrophils/mm2).

Conclusions. An intravascular adenosine mimetic agent exerts cardioprotection during reperfusion by targeting receptor-mediated mechanisms in the intravascular compartment, possibly involving inhibition of neutrophil-related processes.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. Granfeldt, D. J. Lefer, and J. Vinten-Johansen
Protective ischaemia in patients: preconditioning and postconditioning
Cardiovasc Res, July 15, 2009; 83(2): 234 - 246.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Funakoshi, T. O. Chan, J. C. Good, J. R. Libonati, J. Piuhola, X. Chen, S. M. MacDonnell, L. L. Lee, D. E. Herrmann, J. Zhang, et al.
Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function
Circulation, November 21, 2006; 114(21): 2240 - 2250.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Willems, K. J. Ashton, and J. P. Headrick
Adenosine-mediated cardioprotection in the aging myocardium
Cardiovasc Res, May 1, 2005; 66(2): 245 - 255.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X.-M. Yang, J. B. Proctor, L. Cui, T. Krieg, J. M. Downey, and M. V. Cohen
Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways
J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1103 - 1110.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. A. Auchampach, X. Jin, J. Moore, T. C. Wan, L. M. Kreckler, Z.-D. Ge, J. Narayanan, E. Whalley, W. Kiesman, B. Ticho, et al.
Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 846 - 856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, B. Hack, and K. J. Ashton
Acute adenosinergic cardioprotection in ischemic-reperfused hearts
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Muraki, C. D. Morris, J. M. Budde, D. A. Velez, Z.-Q. Zhao, R. A. Guyton, and J. Vinten-Johansen
Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 570 - 579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, D. W. Stepp, D. W. Jones, Y. Nishikawa, and W. M. Chilian
Adenosine preconditions against endothelin-induced constriction of coronary arterioles
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2593 - H2597.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-L. Ma, F. Gao, B. L. Lopez, T. A. Christopher, and J. Vinten-Johansen
Peroxynitrite, a Two-Edged Sword in Post-Ischemic Myocardial Injury---Dichotomy of Action in Crystalloid- Versus Blood-Perfused Hearts
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 912 - 920.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. B. Forman, J. V. Vitola, C. E. Velasco, J. J. Murray, R. K. Dubey, and E. K. Jackson
Sustained Reduction in Myocardial Reperfusion Injury with an Adenosine Receptor Antagonist: Possible Role of the Neutrophil Chemoattractant Response
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 929 - 938.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
K. W. Mahaffey, J. A. Puma, N. A. Barbagelata, M. F. DiCarli, M. A. Leesar, K. F. Browne, P. R. Eisenberg, R. Bolli, A. C. Casas, V. Molina-Viamonte, et al.
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial
J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1711 - 1720.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. H. Thourani, R. S. Ronson, D. G.L. Van Wylen, S. T. Shearer, S. L. Katzmark, Z.-Q. Zhao, D. C. Han, R. A. Guyton, and J. Vinten-Johansen
Adenosine-Supplemented Blood Cardioplegia Attenuates Postischemic Dysfunction After Severe Regional Ischemia
Circulation, November 9, 1999; 100 (2009): II-376 - II-383.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Vinten-Johansen, V. H. Thourani, R. S. Ronson, J. E. Jordan, Z.-Q. Zhao, M. Nakamura, D. Velez, and R. A. Guyton
Broad-spectrum cardioprotection with adenosine
Ann. Thorac. Surg., November 1, 1999; 68(5): 1942 - 1948.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G.-L. Liu, T. A. Christopher, B. L. Lopez, F. Gao, Y. Guo, E. Gao, K. Knuettel, M. Feelisch, and X. L. Ma
SP/W-5186, A Cysteine-Containing Nitric Oxide Donor, Attenuates Postischemic Myocardial Injury
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 527 - 537.
[Abstract] [Full Text]


Home page
PerfusionHome page
D. L Zarro, D. A Palanzo, and F. S Sadr
Myocardial preconditioning using adenosine: review and clinical experience
Perfusion, March 1, 1998; 13(2): 145 - 150.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.